nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP2E1—liver cancer	0.221	0.503	CbGaD
Sildenafil—CYP1A1—liver cancer	0.218	0.497	CbGaD
Sildenafil—ABCC10—Doxorubicin—liver cancer	0.109	0.295	CbGbCtD
Sildenafil—ABCC4—Sorafenib—liver cancer	0.0862	0.234	CbGbCtD
Sildenafil—CYP3A7—Sorafenib—liver cancer	0.0342	0.0929	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0342	0.0929	CbGbCtD
Sildenafil—CYP3A5—Sorafenib—liver cancer	0.0257	0.0697	CbGbCtD
Sildenafil—CYP2C19—Sorafenib—liver cancer	0.0207	0.0562	CbGbCtD
Sildenafil—CYP2C9—Sorafenib—liver cancer	0.0172	0.0467	CbGbCtD
Sildenafil—CYP2D6—Sorafenib—liver cancer	0.0157	0.0427	CbGbCtD
Sildenafil—CYP3A4—Sorafenib—liver cancer	0.01	0.0272	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—liver cancer	0.00955	0.0259	CbGbCtD
Sildenafil—CYP3A4—Doxorubicin—liver cancer	0.00607	0.0165	CbGbCtD
Sildenafil—Pruritus—Sorafenib—liver cancer	0.000185	0.00152	CcSEcCtD
Sildenafil—Ataxia—Epirubicin—liver cancer	0.000185	0.00152	CcSEcCtD
Sildenafil—Osteoarthritis—Doxorubicin—liver cancer	0.000182	0.00149	CcSEcCtD
Sildenafil—Pain in extremity—Doxorubicin—liver cancer	0.000182	0.00149	CcSEcCtD
Sildenafil—Diplopia—Doxorubicin—liver cancer	0.000182	0.00149	CcSEcCtD
Sildenafil—Liver function test abnormal—Epirubicin—liver cancer	0.000182	0.00149	CcSEcCtD
Sildenafil—Orthostatic hypotension—Epirubicin—liver cancer	0.00018	0.00147	CcSEcCtD
Sildenafil—Abdominal pain upper—Epirubicin—liver cancer	0.00018	0.00147	CcSEcCtD
Sildenafil—Migraine—Doxorubicin—liver cancer	0.000179	0.00147	CcSEcCtD
Sildenafil—Hypokalaemia—Epirubicin—liver cancer	0.000179	0.00147	CcSEcCtD
Sildenafil—Diarrhoea—Sorafenib—liver cancer	0.000179	0.00147	CcSEcCtD
Sildenafil—Breast disorder—Epirubicin—liver cancer	0.000178	0.00146	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000177	0.00145	CcSEcCtD
Sildenafil—Nasopharyngitis—Epirubicin—liver cancer	0.000176	0.00144	CcSEcCtD
Sildenafil—Face oedema—Doxorubicin—liver cancer	0.000176	0.00144	CcSEcCtD
Sildenafil—Gastritis—Epirubicin—liver cancer	0.000174	0.00143	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000174	0.00142	CcSEcCtD
Sildenafil—Muscular weakness—Epirubicin—liver cancer	0.000174	0.00142	CcSEcCtD
Sildenafil—Cardiac arrest—Doxorubicin—liver cancer	0.000173	0.00142	CcSEcCtD
Sildenafil—Dizziness—Sorafenib—liver cancer	0.000173	0.00142	CcSEcCtD
Sildenafil—Abdominal distension—Epirubicin—liver cancer	0.000171	0.0014	CcSEcCtD
Sildenafil—Ataxia—Doxorubicin—liver cancer	0.000171	0.0014	CcSEcCtD
Sildenafil—Asthma—Epirubicin—liver cancer	0.00017	0.00139	CcSEcCtD
Sildenafil—Influenza—Epirubicin—liver cancer	0.00017	0.00139	CcSEcCtD
Sildenafil—Dysphagia—Epirubicin—liver cancer	0.00017	0.00139	CcSEcCtD
Sildenafil—Liver function test abnormal—Doxorubicin—liver cancer	0.000168	0.00138	CcSEcCtD
Sildenafil—Vomiting—Sorafenib—liver cancer	0.000166	0.00136	CcSEcCtD
Sildenafil—Abdominal pain upper—Doxorubicin—liver cancer	0.000166	0.00136	CcSEcCtD
Sildenafil—Orthostatic hypotension—Doxorubicin—liver cancer	0.000166	0.00136	CcSEcCtD
Sildenafil—Hypokalaemia—Doxorubicin—liver cancer	0.000166	0.00136	CcSEcCtD
Sildenafil—Angina pectoris—Epirubicin—liver cancer	0.000166	0.00136	CcSEcCtD
Sildenafil—Rash—Sorafenib—liver cancer	0.000165	0.00135	CcSEcCtD
Sildenafil—Dermatitis—Sorafenib—liver cancer	0.000165	0.00135	CcSEcCtD
Sildenafil—Breast disorder—Doxorubicin—liver cancer	0.000165	0.00135	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000164	0.00134	CcSEcCtD
Sildenafil—Headache—Sorafenib—liver cancer	0.000164	0.00134	CcSEcCtD
Sildenafil—Bronchitis—Epirubicin—liver cancer	0.000164	0.00134	CcSEcCtD
Sildenafil—Nasopharyngitis—Doxorubicin—liver cancer	0.000163	0.00133	CcSEcCtD
Sildenafil—Gastritis—Doxorubicin—liver cancer	0.000161	0.00132	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000161	0.00132	CcSEcCtD
Sildenafil—Muscular weakness—Doxorubicin—liver cancer	0.000161	0.00132	CcSEcCtD
Sildenafil—Abdominal distension—Doxorubicin—liver cancer	0.000159	0.0013	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Epirubicin—liver cancer	0.000158	0.0013	CcSEcCtD
Sildenafil—Influenza—Doxorubicin—liver cancer	0.000157	0.00129	CcSEcCtD
Sildenafil—Asthma—Doxorubicin—liver cancer	0.000157	0.00129	CcSEcCtD
Sildenafil—Dysphagia—Doxorubicin—liver cancer	0.000157	0.00129	CcSEcCtD
Sildenafil—Pollakiuria—Epirubicin—liver cancer	0.000157	0.00129	CcSEcCtD
Sildenafil—Nausea—Sorafenib—liver cancer	0.000156	0.00127	CcSEcCtD
Sildenafil—Photosensitivity reaction—Epirubicin—liver cancer	0.000155	0.00127	CcSEcCtD
Sildenafil—Weight increased—Epirubicin—liver cancer	0.000155	0.00127	CcSEcCtD
Sildenafil—Hyperglycaemia—Epirubicin—liver cancer	0.000153	0.00126	CcSEcCtD
Sildenafil—Angina pectoris—Doxorubicin—liver cancer	0.000153	0.00126	CcSEcCtD
Sildenafil—Pneumonia—Epirubicin—liver cancer	0.000153	0.00125	CcSEcCtD
Sildenafil—Infestation NOS—Epirubicin—liver cancer	0.000152	0.00124	CcSEcCtD
Sildenafil—Infestation—Epirubicin—liver cancer	0.000152	0.00124	CcSEcCtD
Sildenafil—Bronchitis—Doxorubicin—liver cancer	0.000151	0.00124	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00015	0.00123	CcSEcCtD
Sildenafil—Renal failure—Epirubicin—liver cancer	0.000149	0.00122	CcSEcCtD
Sildenafil—Neuropathy peripheral—Epirubicin—liver cancer	0.000149	0.00122	CcSEcCtD
Sildenafil—Stomatitis—Epirubicin—liver cancer	0.000148	0.00121	CcSEcCtD
Sildenafil—Urinary tract infection—Epirubicin—liver cancer	0.000147	0.00121	CcSEcCtD
Sildenafil—Conjunctivitis—Epirubicin—liver cancer	0.000147	0.00121	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000146	0.0012	CcSEcCtD
Sildenafil—Sweating—Epirubicin—liver cancer	0.000145	0.00119	CcSEcCtD
Sildenafil—Pollakiuria—Doxorubicin—liver cancer	0.000145	0.00119	CcSEcCtD
Sildenafil—Haematuria—Epirubicin—liver cancer	0.000145	0.00119	CcSEcCtD
Sildenafil—Photosensitivity reaction—Doxorubicin—liver cancer	0.000144	0.00118	CcSEcCtD
Sildenafil—Weight increased—Doxorubicin—liver cancer	0.000143	0.00117	CcSEcCtD
Sildenafil—Epistaxis—Epirubicin—liver cancer	0.000143	0.00117	CcSEcCtD
Sildenafil—Sinusitis—Epirubicin—liver cancer	0.000142	0.00117	CcSEcCtD
Sildenafil—Hyperglycaemia—Doxorubicin—liver cancer	0.000142	0.00116	CcSEcCtD
Sildenafil—Pneumonia—Doxorubicin—liver cancer	0.000141	0.00116	CcSEcCtD
Sildenafil—Infestation NOS—Doxorubicin—liver cancer	0.00014	0.00115	CcSEcCtD
Sildenafil—Infestation—Doxorubicin—liver cancer	0.00014	0.00115	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000139	0.00114	CcSEcCtD
Sildenafil—Renal failure—Doxorubicin—liver cancer	0.000138	0.00113	CcSEcCtD
Sildenafil—Neuropathy peripheral—Doxorubicin—liver cancer	0.000138	0.00113	CcSEcCtD
Sildenafil—Haemoglobin—Epirubicin—liver cancer	0.000137	0.00112	CcSEcCtD
Sildenafil—Stomatitis—Doxorubicin—liver cancer	0.000137	0.00112	CcSEcCtD
Sildenafil—Rhinitis—Epirubicin—liver cancer	0.000137	0.00112	CcSEcCtD
Sildenafil—Conjunctivitis—Doxorubicin—liver cancer	0.000136	0.00112	CcSEcCtD
Sildenafil—Urinary tract infection—Doxorubicin—liver cancer	0.000136	0.00112	CcSEcCtD
Sildenafil—Haemorrhage—Epirubicin—liver cancer	0.000136	0.00112	CcSEcCtD
Sildenafil—Hypoaesthesia—Epirubicin—liver cancer	0.000136	0.00111	CcSEcCtD
Sildenafil—Pharyngitis—Epirubicin—liver cancer	0.000135	0.00111	CcSEcCtD
Sildenafil—Sweating—Doxorubicin—liver cancer	0.000135	0.0011	CcSEcCtD
Sildenafil—Urinary tract disorder—Epirubicin—liver cancer	0.000135	0.0011	CcSEcCtD
Sildenafil—Oedema peripheral—Epirubicin—liver cancer	0.000134	0.0011	CcSEcCtD
Sildenafil—Haematuria—Doxorubicin—liver cancer	0.000134	0.0011	CcSEcCtD
Sildenafil—Connective tissue disorder—Epirubicin—liver cancer	0.000134	0.0011	CcSEcCtD
Sildenafil—Urethral disorder—Epirubicin—liver cancer	0.000134	0.00109	CcSEcCtD
Sildenafil—Epistaxis—Doxorubicin—liver cancer	0.000132	0.00108	CcSEcCtD
Sildenafil—Sinusitis—Doxorubicin—liver cancer	0.000132	0.00108	CcSEcCtD
Sildenafil—Visual impairment—Epirubicin—liver cancer	0.000131	0.00108	CcSEcCtD
Sildenafil—Erythema multiforme—Epirubicin—liver cancer	0.000129	0.00106	CcSEcCtD
Sildenafil—Eye disorder—Epirubicin—liver cancer	0.000127	0.00104	CcSEcCtD
Sildenafil—Tinnitus—Epirubicin—liver cancer	0.000127	0.00104	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—liver cancer	0.000127	0.00104	CcSEcCtD
Sildenafil—Flushing—Epirubicin—liver cancer	0.000126	0.00104	CcSEcCtD
Sildenafil—Cardiac disorder—Epirubicin—liver cancer	0.000126	0.00104	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—liver cancer	0.000126	0.00104	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—liver cancer	0.000126	0.00103	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—liver cancer	0.000125	0.00103	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—liver cancer	0.000125	0.00102	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—liver cancer	0.000124	0.00102	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—liver cancer	0.000124	0.00102	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—liver cancer	0.000124	0.00101	CcSEcCtD
Sildenafil—Angiopathy—Epirubicin—liver cancer	0.000124	0.00101	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—liver cancer	0.000124	0.00101	CcSEcCtD
Sildenafil—Immune system disorder—Epirubicin—liver cancer	0.000123	0.00101	CcSEcCtD
Sildenafil—Mediastinal disorder—Epirubicin—liver cancer	0.000123	0.00101	CcSEcCtD
Sildenafil—Chills—Epirubicin—liver cancer	0.000122	0.001	CcSEcCtD
Sildenafil—Arrhythmia—Epirubicin—liver cancer	0.000122	0.000997	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—liver cancer	0.000121	0.000995	CcSEcCtD
Sildenafil—Alopecia—Epirubicin—liver cancer	0.00012	0.000986	CcSEcCtD
Sildenafil—Mental disorder—Epirubicin—liver cancer	0.000119	0.000978	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—liver cancer	0.000119	0.000976	CcSEcCtD
Sildenafil—Malnutrition—Epirubicin—liver cancer	0.000119	0.000971	CcSEcCtD
Sildenafil—Erythema—Epirubicin—liver cancer	0.000119	0.000971	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—liver cancer	0.000118	0.000965	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—liver cancer	0.000118	0.000963	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—liver cancer	0.000117	0.000958	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—liver cancer	0.000117	0.000958	CcSEcCtD
Sildenafil—Flatulence—Epirubicin—liver cancer	0.000117	0.000957	CcSEcCtD
Sildenafil—Tension—Epirubicin—liver cancer	0.000116	0.000953	CcSEcCtD
Sildenafil—Nervousness—Epirubicin—liver cancer	0.000115	0.000944	CcSEcCtD
Sildenafil—Back pain—Epirubicin—liver cancer	0.000115	0.00094	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—liver cancer	0.000114	0.000937	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—liver cancer	0.000114	0.000933	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—liver cancer	0.000114	0.000931	CcSEcCtD
Sildenafil—Chills—Doxorubicin—liver cancer	0.000113	0.000926	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—liver cancer	0.000113	0.000922	CcSEcCtD
Sildenafil—Vision blurred—Epirubicin—liver cancer	0.000112	0.000916	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—liver cancer	0.000111	0.000912	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—liver cancer	0.00011	0.000905	CcSEcCtD
Sildenafil—Ill-defined disorder—Epirubicin—liver cancer	0.00011	0.000901	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—liver cancer	0.00011	0.000899	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—liver cancer	0.00011	0.000899	CcSEcCtD
Sildenafil—Anaemia—Epirubicin—liver cancer	0.00011	0.000898	CcSEcCtD
Sildenafil—Agitation—Epirubicin—liver cancer	0.000109	0.000893	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—liver cancer	0.000108	0.000886	CcSEcCtD
Sildenafil—Tension—Doxorubicin—liver cancer	0.000108	0.000882	CcSEcCtD
Sildenafil—Malaise—Epirubicin—liver cancer	0.000107	0.000876	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—liver cancer	0.000107	0.000873	CcSEcCtD
Sildenafil—Vertigo—Epirubicin—liver cancer	0.000107	0.000873	CcSEcCtD
Sildenafil—Syncope—Epirubicin—liver cancer	0.000106	0.000871	CcSEcCtD
Sildenafil—Leukopenia—Epirubicin—liver cancer	0.000106	0.00087	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—liver cancer	0.000106	0.000869	CcSEcCtD
Sildenafil—Palpitations—Epirubicin—liver cancer	0.000105	0.000858	CcSEcCtD
Sildenafil—Loss of consciousness—Epirubicin—liver cancer	0.000104	0.000854	CcSEcCtD
Sildenafil—Cough—Epirubicin—liver cancer	0.000103	0.000848	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—liver cancer	0.000103	0.000847	CcSEcCtD
Sildenafil—Convulsion—Epirubicin—liver cancer	0.000103	0.000842	CcSEcCtD
Sildenafil—Hypertension—Epirubicin—liver cancer	0.000102	0.000839	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—liver cancer	0.000102	0.000834	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—liver cancer	0.000101	0.000831	CcSEcCtD
Sildenafil—Chest pain—Epirubicin—liver cancer	0.000101	0.000827	CcSEcCtD
Sildenafil—Arthralgia—Epirubicin—liver cancer	0.000101	0.000827	CcSEcCtD
Sildenafil—Myalgia—Epirubicin—liver cancer	0.000101	0.000827	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—liver cancer	0.000101	0.000826	CcSEcCtD
Sildenafil—Anxiety—Epirubicin—liver cancer	0.000101	0.000824	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.0001	0.000821	CcSEcCtD
Sildenafil—Discomfort—Epirubicin—liver cancer	9.97e-05	0.000817	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—liver cancer	9.89e-05	0.000811	CcSEcCtD
Sildenafil—Dry mouth—Epirubicin—liver cancer	9.87e-05	0.000809	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—liver cancer	9.86e-05	0.000808	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—liver cancer	9.84e-05	0.000806	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—liver cancer	9.82e-05	0.000805	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—liver cancer	9.69e-05	0.000794	CcSEcCtD
Sildenafil—Oedema—Epirubicin—liver cancer	9.68e-05	0.000793	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—liver cancer	9.64e-05	0.00079	CcSEcCtD
Sildenafil—Infection—Epirubicin—liver cancer	9.61e-05	0.000788	CcSEcCtD
Sildenafil—Cough—Doxorubicin—liver cancer	9.57e-05	0.000784	CcSEcCtD
Sildenafil—Shock—Epirubicin—liver cancer	9.52e-05	0.00078	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—liver cancer	9.51e-05	0.000779	CcSEcCtD
Sildenafil—Nervous system disorder—Epirubicin—liver cancer	9.49e-05	0.000778	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—liver cancer	9.47e-05	0.000776	CcSEcCtD
Sildenafil—Tachycardia—Epirubicin—liver cancer	9.44e-05	0.000774	CcSEcCtD
Sildenafil—Skin disorder—Epirubicin—liver cancer	9.4e-05	0.00077	CcSEcCtD
Sildenafil—Hyperhidrosis—Epirubicin—liver cancer	9.35e-05	0.000766	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—liver cancer	9.34e-05	0.000765	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—liver cancer	9.34e-05	0.000765	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—liver cancer	9.34e-05	0.000765	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—liver cancer	9.31e-05	0.000763	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	9.28e-05	0.00076	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—liver cancer	9.23e-05	0.000756	CcSEcCtD
Sildenafil—Anorexia—Epirubicin—liver cancer	9.22e-05	0.000756	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—liver cancer	9.13e-05	0.000748	CcSEcCtD
Sildenafil—Hypotension—Epirubicin—liver cancer	9.04e-05	0.000741	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—liver cancer	8.95e-05	0.000734	CcSEcCtD
Sildenafil—Infection—Doxorubicin—liver cancer	8.9e-05	0.000729	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Epirubicin—liver cancer	8.82e-05	0.000722	CcSEcCtD
Sildenafil—Shock—Doxorubicin—liver cancer	8.81e-05	0.000722	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—liver cancer	8.78e-05	0.000719	CcSEcCtD
Sildenafil—Insomnia—Epirubicin—liver cancer	8.75e-05	0.000717	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—liver cancer	8.74e-05	0.000716	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—liver cancer	8.7e-05	0.000713	CcSEcCtD
Sildenafil—Paraesthesia—Epirubicin—liver cancer	8.69e-05	0.000712	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—liver cancer	8.66e-05	0.000709	CcSEcCtD
Sildenafil—Dyspnoea—Epirubicin—liver cancer	8.63e-05	0.000707	CcSEcCtD
Sildenafil—Somnolence—Epirubicin—liver cancer	8.6e-05	0.000705	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—liver cancer	8.53e-05	0.000699	CcSEcCtD
Sildenafil—Dyspepsia—Epirubicin—liver cancer	8.52e-05	0.000698	CcSEcCtD
Sildenafil—Decreased appetite—Epirubicin—liver cancer	8.41e-05	0.000689	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—liver cancer	8.37e-05	0.000685	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Epirubicin—liver cancer	8.35e-05	0.000684	CcSEcCtD
Sildenafil—Fatigue—Epirubicin—liver cancer	8.34e-05	0.000684	CcSEcCtD
Sildenafil—Constipation—Epirubicin—liver cancer	8.27e-05	0.000678	CcSEcCtD
Sildenafil—Pain—Epirubicin—liver cancer	8.27e-05	0.000678	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—liver cancer	8.16e-05	0.000668	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—liver cancer	8.1e-05	0.000663	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—liver cancer	8.04e-05	0.000659	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—liver cancer	7.98e-05	0.000654	CcSEcCtD
Sildenafil—Feeling abnormal—Epirubicin—liver cancer	7.97e-05	0.000653	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—liver cancer	7.96e-05	0.000652	CcSEcCtD
Sildenafil—Gastrointestinal pain—Epirubicin—liver cancer	7.91e-05	0.000648	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—liver cancer	7.88e-05	0.000646	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—liver cancer	7.78e-05	0.000638	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—liver cancer	7.73e-05	0.000633	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—liver cancer	7.72e-05	0.000632	CcSEcCtD
Sildenafil—Urticaria—Epirubicin—liver cancer	7.69e-05	0.00063	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—liver cancer	7.66e-05	0.000627	CcSEcCtD
Sildenafil—Pain—Doxorubicin—liver cancer	7.66e-05	0.000627	CcSEcCtD
Sildenafil—Body temperature increased—Epirubicin—liver cancer	7.65e-05	0.000627	CcSEcCtD
Sildenafil—Abdominal pain—Epirubicin—liver cancer	7.65e-05	0.000627	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—liver cancer	7.38e-05	0.000605	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—liver cancer	7.32e-05	0.0006	CcSEcCtD
Sildenafil—Hypersensitivity—Epirubicin—liver cancer	7.13e-05	0.000584	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—liver cancer	7.11e-05	0.000583	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—liver cancer	7.08e-05	0.00058	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—liver cancer	7.08e-05	0.00058	CcSEcCtD
Sildenafil—Asthenia—Epirubicin—liver cancer	6.94e-05	0.000569	CcSEcCtD
Sildenafil—Pruritus—Epirubicin—liver cancer	6.85e-05	0.000561	CcSEcCtD
Sildenafil—Diarrhoea—Epirubicin—liver cancer	6.62e-05	0.000542	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—liver cancer	6.6e-05	0.00054	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—liver cancer	6.42e-05	0.000526	CcSEcCtD
Sildenafil—Dizziness—Epirubicin—liver cancer	6.4e-05	0.000524	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—liver cancer	6.33e-05	0.000519	CcSEcCtD
Sildenafil—Vomiting—Epirubicin—liver cancer	6.15e-05	0.000504	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—liver cancer	6.13e-05	0.000502	CcSEcCtD
Sildenafil—Rash—Epirubicin—liver cancer	6.1e-05	0.0005	CcSEcCtD
Sildenafil—Dermatitis—Epirubicin—liver cancer	6.1e-05	0.000499	CcSEcCtD
Sildenafil—Headache—Epirubicin—liver cancer	6.06e-05	0.000497	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—liver cancer	5.92e-05	0.000485	CcSEcCtD
Sildenafil—Nausea—Epirubicin—liver cancer	5.75e-05	0.000471	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—liver cancer	5.69e-05	0.000466	CcSEcCtD
Sildenafil—Rash—Doxorubicin—liver cancer	5.65e-05	0.000463	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—liver cancer	5.64e-05	0.000462	CcSEcCtD
Sildenafil—Headache—Doxorubicin—liver cancer	5.61e-05	0.00046	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—liver cancer	5.32e-05	0.000436	CcSEcCtD
Sildenafil—ABCC4—Hemostasis—HRAS—liver cancer	9.8e-06	0.000137	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTP1—liver cancer	9.79e-06	0.000137	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.79e-06	0.000137	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALDOB—liver cancer	9.76e-06	0.000137	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	9.76e-06	0.000136	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTA2—liver cancer	9.73e-06	0.000136	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—HMOX1—liver cancer	9.66e-06	0.000135	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—liver cancer	9.59e-06	0.000134	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KDR—liver cancer	9.52e-06	0.000133	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTA1—liver cancer	9.47e-06	0.000132	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK14—liver cancer	9.45e-06	0.000132	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PSMA4—liver cancer	9.4e-06	0.000132	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PSMD10—liver cancer	9.4e-06	0.000132	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTA1—liver cancer	9.39e-06	0.000131	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PSMA4—liver cancer	9.39e-06	0.000131	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PSMD10—liver cancer	9.39e-06	0.000131	CbGpPWpGaD
Sildenafil—ABCC5—Disease—STAT3—liver cancer	9.38e-06	0.000131	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NAT2—liver cancer	9.37e-06	0.000131	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CRABP1—liver cancer	9.31e-06	0.00013	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NAT2—liver cancer	9.28e-06	0.00013	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—liver cancer	9.28e-06	0.00013	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ESR1—liver cancer	9.27e-06	0.00013	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—F2—liver cancer	9.16e-06	0.000128	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GOT2—liver cancer	9.15e-06	0.000128	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GOT2—liver cancer	9.13e-06	0.000128	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.01e-06	0.000126	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTM1—liver cancer	9e-06	0.000126	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALDOB—liver cancer	8.98e-06	0.000126	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.93e-06	0.000125	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALDOB—liver cancer	8.9e-06	0.000124	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.89e-06	0.000124	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—liver cancer	8.88e-06	0.000124	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PSMD10—liver cancer	8.87e-06	0.000124	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PSMA4—liver cancer	8.87e-06	0.000124	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CG—liver cancer	8.77e-06	0.000123	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APC—liver cancer	8.77e-06	0.000123	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—liver cancer	8.71e-06	0.000122	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TGFB1—liver cancer	8.69e-06	0.000122	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—liver cancer	8.65e-06	0.000121	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GOT2—liver cancer	8.63e-06	0.000121	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP2E1—liver cancer	8.58e-06	0.00012	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CRABP1—liver cancer	8.57e-06	0.00012	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP1A1—liver cancer	8.53e-06	0.000119	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL6—liver cancer	8.49e-06	0.000119	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CRABP1—liver cancer	8.49e-06	0.000119	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.39e-06	0.000117	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—BRAF—liver cancer	8.24e-06	0.000115	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HPGDS—liver cancer	8.14e-06	0.000114	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2E1—liver cancer	8.11e-06	0.000113	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.09e-06	0.000113	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—liver cancer	8.05e-06	0.000113	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYCS—liver cancer	8.05e-06	0.000113	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYCS—liver cancer	8.03e-06	0.000112	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MTHFR—liver cancer	7.95e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GGT1—liver cancer	7.9e-06	0.00011	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GOT1—liver cancer	7.9e-06	0.00011	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GOT1—liver cancer	7.88e-06	0.00011	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GGT1—liver cancer	7.88e-06	0.00011	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.85e-06	0.00011	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—liver cancer	7.84e-06	0.00011	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARA—liver cancer	7.8e-06	0.000109	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CD—liver cancer	7.71e-06	0.000108	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.65e-06	0.000107	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—liver cancer	7.63e-06	0.000107	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SERPINE1—liver cancer	7.62e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CPT1B—liver cancer	7.6e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GLUL—liver cancer	7.6e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYCS—liver cancer	7.59e-06	0.000106	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—liver cancer	7.55e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HPGDS—liver cancer	7.49e-06	0.000105	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GOT1—liver cancer	7.45e-06	0.000104	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GGT1—liver cancer	7.45e-06	0.000104	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HPGDS—liver cancer	7.42e-06	0.000104	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—liver cancer	7.4e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.38e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.37e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NR1H4—liver cancer	7.33e-06	0.000102	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.28e-06	0.000102	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PSMA4—liver cancer	7.26e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PSMD10—liver cancer	7.26e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA3—liver cancer	7.2e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTP1—liver cancer	7.09e-06	9.92e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTP1—liver cancer	7.08e-06	9.9e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GOT2—liver cancer	7.06e-06	9.87e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HMOX1—liver cancer	7e-06	9.78e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HMOX1—liver cancer	6.98e-06	9.76e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—liver cancer	6.93e-06	9.69e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RAF1—liver cancer	6.88e-06	9.62e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—liver cancer	6.84e-06	9.57e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.72e-06	9.4e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MTOR—liver cancer	6.72e-06	9.39e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CB—liver cancer	6.72e-06	9.39e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTP1—liver cancer	6.69e-06	9.35e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CG—liver cancer	6.68e-06	9.34e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PSMA4—liver cancer	6.67e-06	9.33e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PSMD10—liver cancer	6.67e-06	9.33e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2E1—liver cancer	6.64e-06	9.28e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.64e-06	9.28e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PSMA4—liver cancer	6.62e-06	9.25e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PSMD10—liver cancer	6.62e-06	9.25e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HMOX1—liver cancer	6.6e-06	9.22e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA4—liver cancer	6.59e-06	9.21e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—liver cancer	6.55e-06	9.16e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTM1—liver cancer	6.52e-06	9.12e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTM1—liver cancer	6.51e-06	9.1e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GOT2—liver cancer	6.49e-06	9.08e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARG—liver cancer	6.45e-06	9.02e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GOT2—liver cancer	6.44e-06	9e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.43e-06	8.98e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA2—liver cancer	6.42e-06	8.98e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—liver cancer	6.41e-06	8.97e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1B—liver cancer	6.3e-06	8.82e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—liver cancer	6.24e-06	8.72e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYCS—liver cancer	6.21e-06	8.68e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—liver cancer	6.2e-06	8.66e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA1—liver cancer	6.19e-06	8.66e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1A1—liver cancer	6.18e-06	8.64e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—liver cancer	6.18e-06	8.64e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—liver cancer	6.17e-06	8.63e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1A1—liver cancer	6.17e-06	8.62e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTM1—liver cancer	6.15e-06	8.59e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—liver cancer	6.14e-06	8.58e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NAT2—liver cancer	6.12e-06	8.56e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2E1—liver cancer	6.1e-06	8.54e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GOT1—liver cancer	6.09e-06	8.52e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GGT1—liver cancer	6.09e-06	8.52e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2E1—liver cancer	6.05e-06	8.46e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—liver cancer	6.04e-06	8.45e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—liver cancer	6.01e-06	8.41e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—JUN—liver cancer	6e-06	8.39e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—liver cancer	5.96e-06	8.33e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CD—liver cancer	5.87e-06	8.21e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDOB—liver cancer	5.87e-06	8.21e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.86e-06	8.19e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—liver cancer	5.84e-06	8.16e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1A—liver cancer	5.82e-06	8.14e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALB—liver cancer	5.8e-06	8.11e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MTHFR—liver cancer	5.76e-06	8.06e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MTHFR—liver cancer	5.75e-06	8.04e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYCS—liver cancer	5.71e-06	7.99e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK8—liver cancer	5.68e-06	7.94e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—liver cancer	5.66e-06	7.92e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYCS—liver cancer	5.66e-06	7.92e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARA—liver cancer	5.65e-06	7.9e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARA—liver cancer	5.64e-06	7.89e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GGT1—liver cancer	5.6e-06	7.84e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GOT1—liver cancer	5.6e-06	7.84e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CRABP1—liver cancer	5.6e-06	7.83e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GOT1—liver cancer	5.56e-06	7.77e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GGT1—liver cancer	5.56e-06	7.77e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTP1—liver cancer	5.47e-06	7.65e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MTHFR—liver cancer	5.43e-06	7.6e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMOX1—liver cancer	5.4e-06	7.55e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARA—liver cancer	5.33e-06	7.45e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—liver cancer	5.24e-06	7.33e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—liver cancer	5.19e-06	7.26e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CB—liver cancer	5.12e-06	7.16e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—liver cancer	5.06e-06	7.08e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTP1—liver cancer	5.03e-06	7.04e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTM1—liver cancer	5.03e-06	7.03e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTP1—liver cancer	4.99e-06	6.98e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMOX1—liver cancer	4.96e-06	6.94e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMOX1—liver cancer	4.92e-06	6.88e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HPGDS—liver cancer	4.9e-06	6.85e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CG—liver cancer	4.84e-06	6.77e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CG—liver cancer	4.83e-06	6.75e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—liver cancer	4.82e-06	6.75e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TGFB1—liver cancer	4.81e-06	6.73e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.79e-06	6.69e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1A1—liver cancer	4.77e-06	6.67e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARG—liver cancer	4.67e-06	6.53e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARG—liver cancer	4.66e-06	6.52e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTM1—liver cancer	4.63e-06	6.47e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTM1—liver cancer	4.59e-06	6.41e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CG—liver cancer	4.56e-06	6.38e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—liver cancer	4.46e-06	6.23e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MTHFR—liver cancer	4.44e-06	6.22e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARG—liver cancer	4.4e-06	6.16e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1A1—liver cancer	4.39e-06	6.13e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PSMA4—liver cancer	4.36e-06	6.1e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PSMD10—liver cancer	4.36e-06	6.1e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARA—liver cancer	4.36e-06	6.1e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1A1—liver cancer	4.35e-06	6.08e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CD—liver cancer	4.26e-06	5.95e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CD—liver cancer	4.25e-06	5.94e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GOT2—liver cancer	4.24e-06	5.94e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALB—liver cancer	4.2e-06	5.87e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALB—liver cancer	4.19e-06	5.86e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—liver cancer	4.09e-06	5.73e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MTHFR—liver cancer	4.09e-06	5.72e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MTHFR—liver cancer	4.05e-06	5.67e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CD—liver cancer	4.01e-06	5.61e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARA—liver cancer	4.01e-06	5.61e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2E1—liver cancer	3.99e-06	5.58e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARA—liver cancer	3.98e-06	5.56e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—liver cancer	3.96e-06	5.54e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALB—liver cancer	3.96e-06	5.54e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.92e-06	5.48e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—liver cancer	3.79e-06	5.3e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CG—liver cancer	3.73e-06	5.22e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYCS—liver cancer	3.73e-06	5.22e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CB—liver cancer	3.71e-06	5.19e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CB—liver cancer	3.7e-06	5.18e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GOT1—liver cancer	3.66e-06	5.12e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GGT1—liver cancer	3.66e-06	5.12e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—liver cancer	3.63e-06	5.07e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARG—liver cancer	3.6e-06	5.04e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.57e-06	4.99e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CB—liver cancer	3.5e-06	4.89e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CG—liver cancer	3.43e-06	4.8e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CG—liver cancer	3.41e-06	4.76e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—liver cancer	3.35e-06	4.68e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARG—liver cancer	3.32e-06	4.64e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTP1—liver cancer	3.29e-06	4.6e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARG—liver cancer	3.29e-06	4.6e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CD—liver cancer	3.28e-06	4.59e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMOX1—liver cancer	3.25e-06	4.54e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALB—liver cancer	3.24e-06	4.53e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—liver cancer	3.12e-06	4.36e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTM1—liver cancer	3.02e-06	4.23e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CD—liver cancer	3.02e-06	4.22e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CD—liver cancer	2.99e-06	4.19e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALB—liver cancer	2.98e-06	4.17e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALB—liver cancer	2.96e-06	4.13e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1A1—liver cancer	2.87e-06	4.01e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CB—liver cancer	2.86e-06	4e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MTHFR—liver cancer	2.67e-06	3.74e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CB—liver cancer	2.63e-06	3.68e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARA—liver cancer	2.62e-06	3.67e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CB—liver cancer	2.61e-06	3.65e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—liver cancer	2.55e-06	3.57e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—liver cancer	2.26e-06	3.16e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—liver cancer	2.26e-06	3.16e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CG—liver cancer	2.25e-06	3.14e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARG—liver cancer	2.17e-06	3.03e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—liver cancer	2.13e-06	2.98e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CD—liver cancer	1.97e-06	2.76e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALB—liver cancer	1.95e-06	2.73e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—liver cancer	1.85e-06	2.58e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—liver cancer	1.84e-06	2.58e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—liver cancer	1.74e-06	2.44e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—liver cancer	1.74e-06	2.44e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CB—liver cancer	1.72e-06	2.41e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—liver cancer	1.6e-06	2.24e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—liver cancer	1.59e-06	2.22e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—liver cancer	1.43e-06	1.99e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—liver cancer	1.31e-06	1.83e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—liver cancer	1.3e-06	1.82e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—liver cancer	1.05e-06	1.47e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—liver cancer	8.57e-07	1.2e-05	CbGpPWpGaD
